Back to Search
Start Over
817P Response to olaparib monotherapy in relapsed ovarian cancer by HRR gene mutational status and HRD scarring analysis: Results from the randomized phase II CLIO trial.
- Source :
-
Annals of Oncology . 2020 Supplement 4, Vol. 31, pS617-S618. 2p. - Publication Year :
- 2020
- Subjects :
- *CANCER genes
*OVARIAN cancer
*OLAPARIB
*SCARS
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 31
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152695491
- Full Text :
- https://doi.org/10.1016/j.annonc.2020.08.956